André Dallmann1, Ibrahim Ince2, Michaela Meyer3, Stefan Willmann3, Thomas Eissing4, Georg Hempel1. 1. Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, Westfälische Wilhelm-University Münster, Münster, Germany. 2. ET-TD-ET Systems Pharmacology CV, Bayer AG, Leverkusen, Germany. ibrahim.ince@bayer.com. 3. DD-CS Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany. 4. ET-TD-ET Systems Pharmacology CV, Bayer AG, Leverkusen, Germany.
Abstract
BACKGROUND: In the past years, several repositories for anatomical and physiological parameters required for physiologically based pharmacokinetic modeling in pregnant women have been published. While providing a good basis, some important aspects can be further detailed. For example, they did not account for the variability associated with parameters or were lacking key parameters necessary for developing more detailed mechanistic pregnancy physiologically based pharmacokinetic models, such as the composition of pregnancy-specific tissues. OBJECTIVES: The aim of this meta-analysis was to provide an updated and extended database of anatomical and physiological parameters in healthy pregnant women that also accounts for changes in the variability of a parameter throughout gestation and for the composition of pregnancy-specific tissues. METHODS: A systematic literature search was carried out to collect study data on pregnancy-related changes of anatomical and physiological parameters. For each parameter, a set of mathematical functions was fitted to the data and to the standard deviation observed among the data. The best performing functions were selected based on numerical and visual diagnostics as well as based on physiological plausibility. RESULTS: The literature search yielded 473 studies, 302 of which met the criteria to be further analyzed and compiled in a database. In total, the database encompassed 7729 data. Although the availability of quantitative data for some parameters remained limited, mathematical functions could be generated for many important parameters. Gaps were filled based on qualitative knowledge and based on physiologically plausible assumptions. CONCLUSION: The presented results facilitate the integration of pregnancy-dependent changes in anatomy and physiology into mechanistic population physiologically based pharmacokinetic models. Such models can ultimately provide a valuable tool to investigate the pharmacokinetics during pregnancy in silico and support informed decision making regarding optimal dosing regimens in this vulnerable special population.
BACKGROUND: In the past years, several repositories for anatomical and physiological parameters required for physiologically based pharmacokinetic modeling in pregnant women have been published. While providing a good basis, some important aspects can be further detailed. For example, they did not account for the variability associated with parameters or were lacking key parameters necessary for developing more detailed mechanistic pregnancy physiologically based pharmacokinetic models, such as the composition of pregnancy-specific tissues. OBJECTIVES: The aim of this meta-analysis was to provide an updated and extended database of anatomical and physiological parameters in healthy pregnant women that also accounts for changes in the variability of a parameter throughout gestation and for the composition of pregnancy-specific tissues. METHODS: A systematic literature search was carried out to collect study data on pregnancy-related changes of anatomical and physiological parameters. For each parameter, a set of mathematical functions was fitted to the data and to the standard deviation observed among the data. The best performing functions were selected based on numerical and visual diagnostics as well as based on physiological plausibility. RESULTS: The literature search yielded 473 studies, 302 of which met the criteria to be further analyzed and compiled in a database. In total, the database encompassed 7729 data. Although the availability of quantitative data for some parameters remained limited, mathematical functions could be generated for many important parameters. Gaps were filled based on qualitative knowledge and based on physiologically plausible assumptions. CONCLUSION: The presented results facilitate the integration of pregnancy-dependent changes in anatomy and physiology into mechanistic population physiologically based pharmacokinetic models. Such models can ultimately provide a valuable tool to investigate the pharmacokinetics during pregnancy in silico and support informed decision making regarding optimal dosing regimens in this vulnerable special population.
Authors: C Borghi; D D Esposti; V Immordino; A Cassani; S Boschi; L Bovicelli; E Ambrosioni Journal: Am J Obstet Gynecol Date: 2000-07 Impact factor: 8.661
Authors: Nancy F Butte; Kenneth J Ellis; William W Wong; Judy M Hopkinson; E O'Brian Smith Journal: Am J Obstet Gynecol Date: 2003-11 Impact factor: 8.661
Authors: L C de Groot; H A Boekholt; C K Spaaij; J M van Raaij; J J Drijvers; L J van der Heijden; D van der Heide; J G Hautvast Journal: Am J Clin Nutr Date: 1994-04 Impact factor: 7.045
Authors: Stein Schalkwijk; Rob Ter Heine; Angela Colbers; Edmund Capparelli; Brookie M Best; Tim R Cressey; Rick Greupink; Frans G M Russel; José Moltó; Mark Mirochnick; Mats O Karlsson; David M Burger Journal: J Antimicrob Chemother Date: 2019-05-01 Impact factor: 5.790
Authors: Jamil M Kazma; John van den Anker; Karel Allegaert; André Dallmann; Homa K Ahmadzia Journal: J Pharmacokinet Pharmacodyn Date: 2020-02-06 Impact factor: 2.745
Authors: Xiaomei I Liu; Jeremiah D Momper; Natella Rakhmanina; John N van den Anker; Dionna J Green; Gilbert J Burckart; Brookie M Best; Mark Mirochnick; Edmund V Capparelli; André Dallmann Journal: J Clin Pharmacol Date: 2019-09-06 Impact factor: 3.126
Authors: Xiaomei I Liu; Jeremiah D Momper; Natella Y Rakhmanina; Dionna J Green; Gilbert J Burckart; Tim R Cressey; Mark Mirochnick; Brookie M Best; John N van den Anker; André Dallmann Journal: Clin Pharmacokinet Date: 2020-11 Impact factor: 6.447
Authors: Hongfei Zhang; Hari V Kalluri; Jaime R Bastian; Huijun Chen; Ali Alshabi; Steve N Caritis; Raman Venkataramanan Journal: Br J Clin Pharmacol Date: 2018-06-21 Impact factor: 4.335
Authors: André Dallmann; Ibrahim Ince; Juri Solodenko; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel Journal: Clin Pharmacokinet Date: 2017-12 Impact factor: 6.447
Authors: Shuhui Li; Homa K Ahmadzia; Dong Guo; Elyes Dahmane; Adam Miszta; Naomi L C Luban; Jeffrey S Berger; Andra H James; Alisa S Wolberg; John N van den Anker; Jogarao V S Gobburu Journal: Br J Clin Pharmacol Date: 2021-03-08 Impact factor: 4.335